Literature DB >> 26132435

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter.

Michael E Rich1, Andrew Tseng2, Hae W Lim3, Paul J Wang4, Wilber W Su5.   

Abstract

The cryoballoon catheter ablates atrial fibrillation (AF) triggers in the left atrium (LA) and pulmonary veins (PVs) via transseptal access. The typical transseptal puncture site is the fossa ovalis (FO) - the atrial septum's thinnest section. A potentially beneficial transseptal site, for the cryoballoon, is near the inferior limbus (IL). This study examines an alternative transseptal site near the IL, which may decrease the frequency of acute iatrogenic atrial septal defect (IASD). Also, the study evaluates the acute pulmonary vein isolation (PVI) success rate utilizing the IL location. 200 patients were evaluated by retrospective chart review for acute PVI success rate with an IL transseptal site. An additional 128 IL transseptal patients were compared to 45 FO transseptal patients by performing Doppler intracardiac echocardiography (ICE) post-ablation to assess transseptal flow after removal of the transseptal sheath. After sheath removal and by Doppler ICE imaging, 42 of 128 (33%) IL transseptal patients demonstrated acute transseptal flow, while 45 of 45 (100%) FO transseptal puncture patients had acute transseptal flow. The difference in acute transseptal flow detection between FO and IL sites was statistically significant (P <0.0001). Furthermore, 186 of 200 patients (with an IL transseptal puncture) did not need additional ablation(s) and had achieved an acute PVI by a "cryoballoon only" technique. An IL transseptal puncture site for cryoballoon AF ablations is an effective location to mediate PVI at all four PVs. Additionally, an IL transseptal location can lower the incidence of acute transseptal flow by Doppler ICE when compared to the FO. Potentially, the IL transseptal site may reduce later IASD complications post-cryoballoon procedures.

Entities:  

Mesh:

Year:  2015        PMID: 26132435      PMCID: PMC4544903          DOI: 10.3791/52811

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation.

Authors:  Alexander Fürnkranz; Stefano Bordignon; Daniela Dugo; Laura Perotta; Melanie Gunawardene; Britta Schulte-Hahn; Bernd Nowak; Boris Schmidt; Julian K R Chun
Journal:  J Cardiovasc Electrophysiol       Date:  2014-05-02

2.  Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy.

Authors:  Florian Straube; Uwe Dorwarth; Juergen Vogt; Malte Kuniss; Karl Heinz Kuck; Juergen Tebbenjohanns; Arcadi Garcia Alberola; Kyoung Ryul Julian Chun; Joseph J Souza; Taoufik Ouarrak; Jochen Senges; Johannes Brachmann; Thorsten Lewalter; Ellen Hoffmann
Journal:  Europace       Date:  2014-07-03       Impact factor: 5.214

3.  Persistent iatrogenic atrial septal defect after pulmonary vein isolation by cryoballoon: an under-recognized complication.

Authors:  Ngai-Yin Chan; Chi-Chung Choy; Chun-Leung Lau; Ying-Keung Lo; Pui-Shan Chu; Ho-Chuen Yuen; Ngai-Shing Mok; Ping-Tim Tsui; Suet-Ting Lau
Journal:  Europace       Date:  2011-05-11       Impact factor: 5.214

4.  A rare complication of radiofrequency catheter ablation of left atrial tachycardia: atrial septal dissection and left atrial hematoma formation.

Authors:  Ozgül Uçar; Hülya Ciçekçioğlu; Erdem Diker; Sinan Aydoğdu
Journal:  Turk Kardiyol Dern Ars       Date:  2010-06

5.  New technologies for catheter ablation of atrial fibrillation.

Authors:  Edward P Gerstenfeld
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

6.  Transseptal puncture using minimally invasive echocardiography during atrial fibrillation ablation.

Authors:  Laurens Mitchell-Heggs; Nicolas Lellouche; Leslie Deal; Nathalie Elbaz; Brahim Hamdaoui; Jean-Bernard Castanié; Jean-Luc Dubois-Randé; Pascal Guéret; Pascal Lim
Journal:  Europace       Date:  2010-08-07       Impact factor: 5.214

7.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

8.  Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up.

Authors:  Gian-Battista Chierchia; Giacomo Di Giovanni; Giuseppe Ciconte; Carlo de Asmundis; Giulio Conte; Juan Sieira-Moret; Moises Rodriguez-Mañero; Ruben Casado; Giannis Baltogiannis; Mehdi Namdar; Yukio Saitoh; Gaetano Paparella; Giacomo Mugnai; Pedro Brugada
Journal:  Europace       Date:  2014-01-28       Impact factor: 5.214

9.  One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon.

Authors:  Giacomo DI Giovanni; Kristel Wauters; Gian-Battista Chierchia; Juan Sieira; Moises Levinstein; Giulio Conte; Carlo DE Asmundis; Giannis Baltogiannis; Yukio Saitoh; Giuseppe Ciconte; Justo Julia; Giacomo Mugnai; Ghazala Irfan; Pedro Brugada
Journal:  J Cardiovasc Electrophysiol       Date:  2014-04-09

10.  The 'single big cryoballoon' technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study.

Authors:  Kyoung-Ryul Julian Chun; Boris Schmidt; Andreas Metzner; Roland Tilz; Thomas Zerm; Ilka Köster; Alexander Fürnkranz; Buelent Koektuerk; Melanie Konstantinidou; Matthias Antz; Feifan Ouyang; Karl Heinz Kuck
Journal:  Eur Heart J       Date:  2008-12-24       Impact factor: 29.983

View more
  5 in total

1.  High rate of persistent iatrogenic atrial septal defect after single transseptal puncture for cryoballoon pulmonary vein isolation.

Authors:  Markus Linhart; Jessica T Werner; Florian Stöckigt; Annika T Kohlmann; Pia C Lodde; Lutz P T Linneborn; Thomas Beiert; Christoph Hammerstingl; Roger Borràs; Georg Nickenig; René P Andrié; Jan W Schrickel
Journal:  J Interv Card Electrophysiol       Date:  2018-03-24       Impact factor: 1.900

2.  Heart failure caused by iatrogenic atrial septal defect after cryoballoon ablation for atrial fibrillation.

Authors:  Yasunobu Yamagishi; Yasushi Oginosawa; Kan Kikuchi; Jun Muneuchi; Keishiro Yagyu; Taro Miyamoto; Keita Tsukahara; Hisaharu Ohe; Ritsuko Kohno; Haruhiko Abe
Journal:  J Cardiol Cases       Date:  2021-07-07

3.  Persistence of an iatrogenic atrial septal defect after a second-generation cryoballoon ablation of atrial fibrillation.

Authors:  Tomonori Watanabe; Shinsuke Miyazaki; Takatsugu Kajiyama; Sadamitsu Ichijo; Takamitsu Takagi; Miyako Igarashi; Hiroaki Nakamura; Hiroshi Taniguchi; Hitoshi Hachiya; Yoshito Iesaka
Journal:  Heart Vessels       Date:  2018-03-17       Impact factor: 2.037

4.  Hemodynamically significant iatrogenic atrial septal defects after cryoballoon ablation.

Authors:  Jayasheel Eshcol; Alan P Wimmer
Journal:  HeartRhythm Case Rep       Date:  2018-10-09

Review 5.  A tale of two balloons: technical and procedural difference between cryoballoon systems.

Authors:  Emrie Tomaiko-Clark; Rong Bai; Mateen Khokhar; Wilber W Su
Journal:  Curr Opin Cardiol       Date:  2022-01-01       Impact factor: 2.161

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.